The present findings suggest that the incongruent reduction of DAT availability in different subgroups of AD may play a pathophysiological role in the development of AD, and different drinking behaviors may influence the stabilization of brain dopamine levels. This evidence concerns the gene SLC6A3 and Alzheimer disease.